SATYLIA
Food supplement declared in France, declaration No 2020-1-1236
SATYLIA (SYMBIOSYS) is a food supplement declared in France. Status: retiré du marché le 25 December 2023. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- SYMBIOSYS
- Food business operator placing the product on the market
- BIOCODEX
- Status
- Retiré du marché le 25 December 2023
- Form
- Gélule
- Daily dose
- 2 gélules par jour
- Directions for use
- A avaler avec un verre d'eau, 2 gélules par jour, 1 au petit déjeuner et 1 au déjeuner
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Minceur / Glycémie
Declaration 216635, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 25 December 2023, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Micro-organisms
| Strain | Per day |
|---|---|
| Hafnia alvei Hafnia alvei HA4597 | 50,000,000 (unit not declared) |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Picolinate de chrome | Chrome | pas de limite (données insuffisantes) | 25 µg |
| Bisglycinate de zinc | Zinc | 25 mg | 15 mg |
Additives
E464, E418, E470b
Other ingredients
amidon de maïs
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne doit pas se substituer à un mode de vie sain et à une alimentation équilibrée et variée. Ne pas dépasser la dose journalière recommandée. Tenir hors de la portée des enfants. Toujours fermer le tube après utilisation. Conserver à température ambiante, dans un endroit sec, à l'abri de la chaleur.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Satylia Symbiosys, declared in 2026 : different composition: 3 ingredient(s) added, 4 missing
- Satylia Symbiosys, declared in 2023 : different composition: 3 ingredient(s) added, 4 missing
Brand : SYMBIOSYS